SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life…
SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international…
Series B financing led by HM Capital and joined by returning investors JJDC and Medvest Capital Proceeds will support clinical…
Männedorf, Switzerland, March 8, 2022 – The Tecan Group (SIX Swiss Exchange: TECN) will hold an Analyst and Media conference…
Picture 1 Recently posted YouTube video about Whitney Johns. Picture 2 Recently posted YouTube video about UBN RELIEF benefits.LAS VEGAS,…
-Acre-scale seed production planned in spring 2022 -First winter PHA Camelina planting expected in fall 2022 -Research program to produce…
JERSEY CITY, N.J., March 08, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome…
Application website is now open for the 2022 Scholarship ProgramFor the 2022-2023 academic year, the scholarship program has expanded to…
Exclusive extension of research discovery collaboration with Mass General Hospital (MGH)Focus of the program: development of novel oral SIK inhibitors…
MINNEAPOLIS, March 08, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for…